MEDICAL VIROLOGY VI

Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

MEDICAL VIROLOGY VI

Med Virol; 6:1-412 1987. Unique Identifier : AIDSLINE ICDB/88648580
Anonymous; No affiliation given

Abstract: This volume contains the proceedings of the 1986 International Symposium on Medical Virology, held November 12-14, 1986, in Anaheim, California. The symposium was an attempt to bring together individuals working in different areas of medical virology to exchange information that will help in effective control of viral diseases. Full length papers presented include prospects for application of monoclonal antibody (MoAb) technology and MoAb-drug conjugates to viral disease; clinical presentation and laboratory diagnosis of Chlamydia infections; perturbation of host cell function during persistent viral infection; slow infections of the CNS; clinical and immunopathological manifestations and detection of Epstein-Barr virus infection in immune-deficient patients; hemorrhagic fever with renal syndrome (global epidemiology and ecology of hantavirus infections); natural history of viruses of the intestine in contrasting ecosystems; biology, pathogenic potential, and diagnosis of papovaviruses; DNA viruses in anogenital cancer; type D virus immunosuppression in captive macaques; human T lymphotropic retroviruses; viral receptors as a novel approach for the prevention of human rhinovirus infection; the role of interferon (IFN) in resistance to infection and toxic effects of endogenous and exogenous IFN; and amantadine and rimantadine in the prophylaxis and therapy of influenza A. In addition, abstracts are included of presentations covering the following topics: rapid detection of cytomegalovirus (CMV), herpes simplex virus (HSV) isolation, direct detection of proteins associated with human T-lymphotropic virus (HTLV) III, detection of antibody to HIV, influenza surveillance, serodiagnosis of rabies, detection of group A rotaviruses, the Enzygnost test as a screen for varicella zoster virus, evidence of HTLVs in systemic lupus erythematosus, prevalence of AIDS-associated retroviruses in the Naples (Italy) area, transmission route of feline retrovirus infection in cats, prevention of CMV infection in immunocompromised children, CMV infection in hospitals, Hemophilus influenzae B infection and CMV, MoAbs against HTLV III, rubella virus interactions with human lymphoid cells, acyclovir in HSV encephalitis, evaluation of 3-deazacytidine and 3-deazauridines, antiviral activity of recombinant murine tumor necrosis factor-alpha and recombinant murine IFN-gamma.

Keywords: Congresses Human *Virus Diseases/DIAGNOSIS/IMMUNOLOGY/MICROBIOLOGY MONOGRAPH CONGRESS

881230
M88C0647

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .